Adelante is making whole-body MRI scans 10x cheaper with a mobile trailer that shows up outside clinics
Jun 16, 2026 · Full transcript · This transcript is auto-generated and may contain errors.
Featuring Efrain Torres
Speaker 2: Yeah.
Speaker 1: Be probably be like a $100,000,000,000,000 company. Anyway, our next guest might be building the next $100,000,000,000,000 company. We have Payton Case from dispatch here, building reentry vehicles. We're returning space manufactured payloads in semiconductor biotech and pharma. Welcome to the show, Payton. How are you doing? Oh, wait. Sorry. Do I have the wrong person?
Speaker 5: Wrong. I think that was
Speaker 1: a mix up of this. Oh, we switched around. Efraen Torres. Efraen. Thank you. Please introduce yourself for us so we get it correct.
Speaker 5: Yeah. So, hi. My name is Efraen Torres. We're from body mobile MRIs for cancer screening.
Speaker 1: Amazing. There we go. Are there any downsides to constantly getting MRIs?
Speaker 5: No. So MRI is non cancer causing radiation.
Speaker 1: Okay.
Speaker 5: CT and x-ray, there's limitations.
Speaker 1: Got
Speaker 5: it. But MRI, I mean, I I've scanned myself thousands of times.
Speaker 1: So Are you the
Speaker 2: most scanned person in history?
Speaker 5: No. My professor takes that one. He he's he likes to tell he's the most scanned and published brain in the in the history of Mankind.
Speaker 1: Five times a day or something?
Speaker 5: Yeah. That's how you get it. Yeah.
Speaker 1: How how mobile are we talking? Are we talking mobile like, it can be in a truck that comes to the town and you go, like, getting your body fat measured in a water tank? Or are we talking, like, Fitbit? I clip it to my my waistband, and I'm constantly getting MRI.
Speaker 5: Yeah. No. We're talking trailer. So we bought, like, a Ford three fifty, shows up outside of a clinic.
Speaker 2: Just give it a
Speaker 1: I like the Ford three fifty.
Speaker 5: There you go. Right? We we actually calculated it just for that. Yeah. Okay. This whole body screen
Speaker 1: Yeah.
Speaker 5: $250, and there you go.
Speaker 1: $2.50. Okay. Okay. So what So what And I'm getting a little feedback here right now. Can we deal with that? Thank you. So yeah. Sorry.
Speaker 2: What does a normal MRI cost?
Speaker 5: Yeah. I mean, Pernuvo, if you look at their pricing, they're $2,500. Mhmm. And it can go up to $3,500. We're around 10 times cheaper
Speaker 1: 10 times cheaper.
Speaker 5: Than everything on the market.
Speaker 2: And what is driving that?
Speaker 5: Yeah. So there's two things. The first thing is our technology. Like, our system is 80% lighter Mhmm. Consumes 60% less power. It's actually eight times quieter too. Mhmm. And all of this lets us have the operational gains. So we don't sell the systems, we sell scans. So it makes our internal operation costs really low. Interesting. And the shelf life of these systems are ten to twelve years. So we can charge $2.50 a scan and actually our gross margin actually ends up being 55% because of how long these systems last.
Speaker 1: Do you have to go through medical device approval with the FDA?
Speaker 5: Yeah. No. We're we're going through medical device approval next year as a class two five ten k.
Speaker 11: Got it.
Speaker 5: It's a fairly straightforward path because of the fact that there's a lot of regulatory precedents.
Speaker 1: Yeah.
Speaker 5: Where there's the regulatory risk arises when you're like the first MRI Yeah. First therapeutic and things like that.
Speaker 1: Well then, what about Okay.
Speaker 2: So what's the backstory on the on the company and the IP? Did you cook this up with your professor? Is he is he involved with business? What's what's the history?
Speaker 5: Yeah. No. Not the professor. He's not involved. So me me and my co founder, we've known each other ten years, went to grad school together, specifically to spin out a startup MRI is the industry, if you think about it. And so we developed an IP in grad school, got that patent issued, Adelante has exclusive rights to it. And yes, it's been it's been cooking for a good bit here. But MRI is a hard problem to solve and that's why it's it's taken us yeah. Doing well.
Speaker 2: So Very cool.
Speaker 1: You're so you're going through FDA approval. Can you actually sell the product at in some advanced form yet, or is it just, like, demonstration for medical for, like, research purposes at this point?
Speaker 5: Yeah. So I love this question because it's got to one of the the creativity of of our company. We are deploying this year based of traditional MRIs. Oh. The traditional MRIs, we're gonna put them in semi trucks and it's all FDA cleared.
Speaker 1: Okay.
Speaker 5: We can go to our customers. We have 11 LOIs already, 19,750,000
Speaker 1: Mhmm.
Speaker 5: And start building that distribution channel now.
Speaker 1: Yeah.
Speaker 5: And over the next year, right, we're gonna get five to 10 of these trailers out there
Speaker 1: Yep.
Speaker 5: All breaking even. But then come q one twenty twenty eight when our product is cleared, you just switch it and it's like a lever to profitability.
Speaker 1: That's amazing. Wow. Congratulations. You're
Speaker 5: Thank you.
Speaker 1: How's the fundraising been going?
Speaker 5: It's been going well. Have we only have a small amount of allocation left of our non leads and having a lot of exciting conversations with potential leads.
Speaker 1: Are you more are you seeing more interest from investors who have invested in health tech, medical tech, FDA approved devices, that crowd? Because or or or are there tech investors who are sort of exhausted with the AI stuff and wanna broaden their horizons?
Speaker 5: Yeah. Honestly, we're getting a lot of interest from deep tech, generalists, and just tech. Yeah. Because MRI is very well known in this space. You have Purnubo.
Speaker 1: Yeah.
Speaker 5: Everyone has a story of someone that didn't get an MRI in time. Mhmm. Whether it be from like a sports injury to something more severe like the cancer wasn't caught in time. Mhmm. And so we're we've had interest from deep tech Cool. Tech investors, generalists, health tech as well.
Speaker 2: Well, congrats Where's the name from? I gotta know.
Speaker 5: Yeah. So so call credit goes to my wife. So Adeelante stands for a couple of things. Our scientific approaches are known as radio frequency adiabatic pulses.
Speaker 1: Mhmm.
Speaker 5: And my my my parents saying is which in Spanish is keep going forward. Also tattooed on my forearm here.
Speaker 2: There we go.
Speaker 5: And so Adeelante is very close to Adelante, which means go forward in Spanish, and it kind of goes that no matter what happens to us, we're just gonna keep on making progress every single day.
Speaker 1: Very cool. Thank you so much for coming on the show.
Speaker 2: Logo. Logo. Logo. Piece.
Speaker 9: I'll
Speaker 1: speak soon. Yeah. Talk soon. Have a good one.
Speaker 5: Likewise. Yeah.
Speaker 1: Up next, we have a good buddy of mine, Russell Smith from nine mothers. He's back in y C. I went through Y C with him in summer of twenty twelve, fourteen years ago. Overnight success. There
Speaker 2: we go.
Speaker 1: But I'm excited to catch up with Russell Smith, introduce him to everyone.
Speaker 2: Tyler was was what? One or two?
Speaker 1: He was probably
Speaker 2: He was seven years old or something. Just a boy.
Speaker 1: Years old. Yeah. Just a boy. But he's working on AI mission systems for